BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 16102249)

  • 1. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties.
    Barnes J; Anderson LA; Gibbons S; Phillipson JD
    J Pharm Pharmacol; 2005 Aug; 57(8):929-54. PubMed ID: 16102249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical application of extracts of Echinacea purpurea or Echinacea pallida. Critical evaluation of controlled clinical studies].
    Dorsch W
    Z Arztl Fortbild (Jena); 1996 Apr; 90(2):117-22. PubMed ID: 8686334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Echinacea drugs--effects and active ingredients].
    Bauer R
    Z Arztl Fortbild (Jena); 1996 Apr; 90(2):111-5. PubMed ID: 8686333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in immunomodulatory properties of Echinacea spp. root infusions and tinctures stored at 4 degrees C for four days.
    Senchina DS; McCann DA; Asp JM; Johnson JA; Cunnick JE; Kaiser MS; Kohut ML
    Clin Chim Acta; 2005 May; 355(1-2):67-82. PubMed ID: 15820480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune system effects of echinacea, ginseng, and astragalus: a review.
    Block KI; Mead MN
    Integr Cancer Ther; 2003 Sep; 2(3):247-67. PubMed ID: 15035888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence characterized amplified region (SCAR) analysis on DNA from the three medicinal Echinacea species.
    Adinolfi B; Chicca A; Martinotti E; Breschi MC; Nieri P
    Fitoterapia; 2007 Jan; 78(1):43-5. PubMed ID: 17067760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic effects of Echinacea root hexanic extracts on human cancer cell lines.
    Chicca A; Adinolfi B; Martinotti E; Fogli S; Breschi MC; Pellati F; Benvenuti S; Nieri P
    J Ethnopharmacol; 2007 Mar; 110(1):148-53. PubMed ID: 17052874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of phenolic constituents in Echinacea purpurea grown in China.
    Liu YC; Zeng JG; Chen B; Yao SZ
    Planta Med; 2007 Dec; 73(15):1600-5. PubMed ID: 18058611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
    Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A
    J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echinacea extracts modulate the pattern of chemokine and cytokine secretion in rhinovirus-infected and uninfected epithelial cells.
    Sharma M; Arnason JT; Burt A; Hudson JB
    Phytother Res; 2006 Feb; 20(2):147-52. PubMed ID: 16444669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a standardized extract from Echinacea angustifolia (Polinacea) for the prevention of respiratory tract infections.
    Di Pierro F; Rapacioli G; Ferrara T; Togni S
    Altern Med Rev; 2012 Mar; 17(1):36-41. PubMed ID: 22502621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herbal extracts used for upper respiratory tract infections: are there clinically relevant interactions with the cytochrome P450 enzyme system?
    Heinrich M; Modarai M; Kortenkamp A
    Planta Med; 2008 May; 74(6):657-60. PubMed ID: 18584812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical methods for the study of bioactive compounds from medicinally used Echinacea species.
    Bruni R; Brighenti V; Caesar LK; Bertelli D; Cech NB; Pellati F
    J Pharm Biomed Anal; 2018 Oct; 160():443-477. PubMed ID: 30142565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts.
    Chicca A; Raduner S; Pellati F; Strompen T; Altmann KH; Schoop R; Gertsch J
    Int Immunopharmacol; 2009 Jul; 9(7-8):850-8. PubMed ID: 19303464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous analysis of alkamides and caffeic acid derivatives for the identification of Echinacea purpurea, Echinacea angustifolia, Echinacea pallida and Parthenium integrifolium roots.
    Laasonen M; Wennberg T; Harmia-Pulkkinen T; Vuorela H
    Planta Med; 2002 Jun; 68(6):572-4. PubMed ID: 12094312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of quantitative flow cytometry to measure ex vivo immunostimulant activity of echinacea: the case for polysaccharides.
    Pillai S; Pillai C; Mitscher LA; Cooper R
    J Altern Complement Med; 2007; 13(6):625-34. PubMed ID: 17718645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [History of a plant: the example of Echinacea].
    Hostettmann K
    Forsch Komplementarmed Klass Naturheilkd; 2003 Apr; 10 Suppl 1():9-12. PubMed ID: 12808356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-herpetic properties of hydroalcoholic extracts and pressed juice from Echinacea pallida.
    Schneider S; Reichling J; Stintzing FC; Messerschmidt S; Meyer U; Schnitzler P
    Planta Med; 2010 Feb; 76(3):265-72. PubMed ID: 19790030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echinacea for upper respiratory infection.
    Barrett B; Vohmann M; Calabrese C
    J Fam Pract; 1999 Aug; 48(8):628-35. PubMed ID: 10496642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic characterization of the three medicinal Echinacea species using RAPD analysis.
    Nieri P; Adinolfi B; Morelli I; Breschi MC; Simoni G; Martinotti E
    Planta Med; 2003 Jul; 69(7):685-6. PubMed ID: 12898432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.